tert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine

C50H67N19O3Si — CID 163417400

IUPACtert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine
SMILESCc1cnc(NC2CCCCC2)nc1-c1c[nH]c2nc(-n3nnnc3C)ccc12.Cc1cnc(N[C@H]2CCCN(C(=O)OC(C)(C)C)C2)nc1-c1cn(COCC[Si](C)(C)C)c2nc(-n3nnnc3C)ccc12
InChIInChI=1S/C30H44N10O3Si.C20H23N9/c1-20-16-31-28(32-22-10-9-13-38(17-22)29(41)43-30(3,4)5)34-26(20)24-18-39(19-42-14-15-44(6,7)8)27-23(24)11-12-25(33-27)40-21(2)35-36-37-40;1-12-10-22-20(23-14-6-4-3-5-7-14)25-18(12)16-11-21-19-15(16)8-9-17(24-19)29-13(2)26-27-28-29/h11-12,16,18,22H,9-10,13-15,17,19H2,1-8H3,(H,31,32,34);8-11,14H,3-7H2,1-2H3,(H,21,24)(H,22,23,25)/t22-;/m0./s1
InChIKeyAFPKAZLNQALLKE-FTBISJDPSA-N
MW1010.30 g/mol
LogP8.57
Rot. Bonds13

About tert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine

tert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine (PubChem CID 163417400) has the molecular formula C50H67N19O3Si and a molecular weight of 1010.30 g/mol. Its IUPAC name is tert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine.

Molecular Properties

Compound Nametert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine
PubChem CID163417400
Molecular FormulaC50H67N19O3Si
Molecular Weight1010.30 g/mol
Exact Mass1009.54
IUPAC Nametert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine
SMILESCc1cnc(NC2CCCCC2)nc1-c1c[nH]c2nc(-n3nnnc3C)ccc12.Cc1cnc(N[C@H]2CCCN(C(=O)OC(C)(C)C)C2)nc1-c1cn(COCC[Si](C)(C)C)c2nc(-n3nnnc3C)ccc12
InChIInChI=1S/C30H44N10O3Si.C20H23N9/c1-20-16-31-28(32-22-10-9-13-38(17-22)29(41)43-30(3,4)5)34-26(20)24-18-39(19-42-14-15-44(6,7)8)27-23(24)11-12-25(33-27)40-21(2)35-36-37-40;1-12-10-22-20(23-14-6-4-3-5-7-14)25-18(12)16-11-21-19-15(16)8-9-17(24-19)29-13(2)26-27-28-29/h11-12,16,18,22H,9-10,13-15,17,19H2,1-8H3,(H,31,32,34);8-11,14H,3-7H2,1-2H3,(H,21,24)(H,22,23,25)/t22-;/m0./s1
InChIKeyAFPKAZLNQALLKE-FTBISJDPSA-N
XLogP8.57
TPSA248.09 Ų
H-Bond Donors3
H-Bond Acceptors20
Rotatable Bonds13
Heavy Atoms73
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001010.30
LogP ≤ 58.57
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze tert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine?
The IUPAC name of tert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine (CID 163417400) is tert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine.
What is the SMILES notation for tert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine?
The canonical SMILES for tert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine is Cc1cnc(NC2CCCCC2)nc1-c1c[nH]c2nc(-n3nnnc3C)ccc12.Cc1cnc(N[C@H]2CCCN(C(=O)OC(C)(C)C)C2)nc1-c1cn(COCC[Si](C)(C)C)c2nc(-n3nnnc3C)ccc12.
What is the InChIKey of tert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine?
The InChIKey is AFPKAZLNQALLKE-FTBISJDPSA-N. The full InChI is InChI=1S/C30H44N10O3Si.C20H23N9/c1-20-16-31-28(32-22-10-9-13-38(17-22)29(41)43-30(3,4)5)34-26(20)24-18-39(19-42-14-15-44(6,7)8)27-23(24)11-12-25(33-27)40-21(2)35-36-37-40;1-12-10-22-20(23-14-6-4-3-5-7-14)25-18(12)16-11-21-19-15(16)8-9-17(24-19)29-13(2)26-27-28-29/h11-12,16,18,22H,9-10,13-15,17,19H2,1-8H3,(H,31,32,34);8-11,14H,3-7H2,1-2H3,(H,21,24)(H,22,23,25)/t22-;/m0./s1.
What are the key properties of tert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine?
tert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine has a molecular weight of 1010.30 g/mol, XLogP of 8.57, 13 rotatable bonds, 3 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl (3S)-3-[[5-methyl-4-[6-(5-methyltetrazol-1-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-yl]amino]piperidine-1-carboxylate;N-cyclohexyl-5-methyl-4-[6-(5-methyltetrazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine is sourced from PubChem (CID 163417400), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).